ANG LI to Rituximab
This is a "connection" page, showing publications ANG LI has written about Rituximab.
Connection Strength
0.195
-
Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura. Blood Adv. 2019 05 14; 3(9):1512-1518.
Score: 0.140
-
Immune Thrombotic Thrombocytopenic Purpura: A Review. JAMA. 2025 08 12; 334(6):517-529.
Score: 0.054
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.